Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium hydroxyapatite is the primary inorganic mineral constituent of vertebrate bones and dental enamel, representing approximately 97% of enamel by weight and 70% of dentin. It provides essential structural rigidity, hardness, and load-bearing capacity to the skeletal and dental systems. In clinical medicine and dentistry, hydroxyapatite serves as a critical therapeutic target for managing bone resorption disorders and dental decay. Bisphosphonates, such as zoledronic acid and alendronate, exhibit an extremely high affinity for hydroxyapatite, binding to the mineral surface to concentrate in bone tissue where they subsequently inhibit osteoclast activity and reduce bone turnover. In oral care, fluoride ions interact with hydroxyapatite to substitute hydroxyl groups, forming fluorapatite, which is significantly more resistant to acid-mediated demineralization. Additionally, biomimetic synthetic hydroxyapatite and enamel-targeting peptides are utilized in remineralizing toothpastes and therapies to physically deposit calcium and phosphate back into microscopic enamel defects, restoring mineral density and reducing dentin hypersensitivity.
Bisphosphonates adsorb to calcium hydroxyapatite to target bone tissue and inhibit osteoclast-mediated bone resorption. Fluoride ions substitute hydroxyl groups in the hydroxyapatite lattice to form acid-resistant fluorapatite. Biomimetic peptides and synthetic hydroxyapatite deposit calcium and phosphate directly onto demineralized enamel surfaces to restore mineral density and seal dentinal tubules.
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium hydroxyapatite (HAp).